Targeting the tumor microenvironment: from understanding pathways to effective clinical trials.

Abstract

It is clear that tumor cells do not act alone but in close interaction with the extracellular matrix and with stromal cells in the tumor microenvironment (TME). As our understanding of tumor cell-stroma interactions increased over the last two decades, significant efforts have been made to develop agents that interfere with these interactions. Here, we discuss four different therapeutic strategies that target the TME, focusing on agents that are at the most advanced stage of preclinical or clinical development. We end this review by outlining some of the lessons we have learned so far from the development of TME-targeting agents.

DOI: 10.1158/0008-5472.CAN-13-0661
010020030020132014201520162017
Citations per Year

553 Citations

Semantic Scholar estimates that this publication has 553 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Fang2013TargetingTT, title={Targeting the tumor microenvironment: from understanding pathways to effective clinical trials.}, author={Hua Fang and Yves A DeClerck}, journal={Cancer research}, year={2013}, volume={73 16}, pages={4965-77} }